Juntendo University Hospital

Bunkyo, Tokyo 113-8431

0 studies enrolling now · 6 studies all time

What they study most

Autologous Stem Cell Transplant, Children, Contrast Enhancement in Magnetic Resonance Imaging, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Hereditary Angioedema, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Multiple Myeloma, Myelodysplastic Syndrome, Primary Peritoneal Carcinoma

Studies at this site

• A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric) — Completed
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) — Completed
• Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial — Completed
• CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks — Completed